Matti Sällberg

InstitutionKarolinska Institutet
AddressStockholm
Sweden
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 3 Covid-19 publications, with a maximum of 1 publications in August 2020 and Spetember 2020 and July 2021
    All Publications
    Bar chart showing 51 publications over 19 distinct years, with a maximum of 6 publications in 2013
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Sandberg JT, Varnaite R, Christ W, Chen P, Muvva JR, Maleki KT, García M, Dzidic M, Folkesson E, Skagerberg M, Ahlén G, Frelin L, Sällberg M, Eriksson LI, Rooyackers O, Sönnerborg A, Buggert M, Björkström NK, Aleman S, Strålin K, Klingström J, Ljunggren HG, Blom K, Gredmark-Russ S. SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation. Clin Transl Immunology. 2021; 10(7):e1306. PMID: 34257967.
      Citations: 7     
    2. Varnaite R, García M, Glans H, Maleki KT, Sandberg JT, Tynell J, Christ W, Lagerqvist N, Asgeirsson H, Ljunggren HG, Ahlén G, Frelin L, Sällberg M, Blom K, Klingström J, Gredmark-Russ S. Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients. J Immunol. 2020 11 01; 205(9):2437-2446. PMID: 32878912.
      Citations: 26     Fields:    Translation:HumansCellsPHPublic Health
    3. Ahlén G, Frelin L, Nikouyan N, Weber F, Höglund U, Larsson O, Westman M, Tuvesson O, Gidlund EK, Cadossi M, Appelberg S, Mirazimi A, Sällberg M. The SARS-CoV-2 N Protein Is a Good Component in a Vaccine. J Virol. 2020 08 31; 94(18). PMID: 32661140.
      Citations: 5     Fields:    Translation:HumansCellsPHPublic Health
    4. Lybeck C, Brenndörfer ED, Sällberg M, Montgomery SM, Aleman S, Duberg AS. Long-term follow-up after cure from chronic hepatitis C virus infection shows occult hepatitis and a risk of hepatocellular carcinoma in noncirrhotic patients. Eur J Gastroenterol Hepatol. 2019 04; 31(4):506-513. PMID: 30461522.
      Citations: 3     Fields:    Translation:HumansCells
    5. Psaros Einberg A, Brenndörfer ED, Frelin L, Hallberg L, Sällberg M, Fischler B. Neonatal Exposure to Hepatitis C Virus Antigens in Uninfected Children Born to Infected Mothers. J Pediatr Gastroenterol Nutr. 2018 01; 66(1):106-111. PMID: 28953534.
      Citations:    Fields:    Translation:HumansCells
    6. Psaros Einberg A, Duberg AS, Filipovich O, Nyström J, Zhirkov A, Brenndörfer ED, Frelin L, Rukoiatkina E, Lobzin Y, Sällberg M, Fischler B, Lutckii A. Lack of Association Between Interleukin 28B Polymorphism and Vertical Transmission of Hepatitis C. J Pediatr Gastroenterol Nutr. 2017 12; 65(6):608-612. PMID: 28820758.
      Citations:    Fields:    Translation:HumansCells
    7. Levander S, Holmström F, Frelin L, Ahlén G, Rupp D, Long G, Bartenschlager R, Sällberg M. Immune-mediated effects targeting hepatitis C virus in a syngeneic replicon cell transplantation mouse model. Gut. 2018 08; 67(8):1525-1535. PMID: 28646094.
      Citations: 1     Fields:    Translation:AnimalsCells
    8. Davanian H, Balasiddaiah A, Heymann R, Sundström M, Redenström P, Silfverberg M, Brodin D, Sällberg M, Lindskog S, Kruger Weiner C, Chen M. Ameloblastoma RNA profiling uncovers a distinct non-coding RNA signature. Oncotarget. 2017 Jan 17; 8(3):4530-4542. PMID: 27965463.
      Citations: 5     Fields:    Translation:HumansCells
    9. Levander S, Sällberg M, Ahlén G, Frelin L. A non-human hepadnaviral adjuvant for hepatitis C virus-based genetic vaccines. Vaccine. 2016 05 27; 34(25):2821-33. PMID: 27109565.
      Citations: 4     Fields:    Translation:HumansAnimalsCells
    10. Ahlén G, Frelin L, Holmström F, Smetham G, Augustyn S, Sällberg M. A targeted controlled force injection of genetic material in vivo. Mol Ther Methods Clin Dev. 2016; 5:16016. PMID: 27069951.
      Citations: 2     
    11. Chen M, Jagya N, Bansal R, Frelin L, Sällberg M. Prospects and progress of DNA vaccines for treating hepatitis B. Expert Rev Vaccines. 2016 May; 15(5):629-40. PMID: 26652035.
      Citations: 2     Fields:    Translation:Humans
    12. Bansal R, Frelin L, Brenndörfer ED, Storm G, Prakash J, Sällberg M. Hepatitis C Virus Nonstructural 3/4A Protein Dampens Inflammation and Contributes to Slow Fibrosis Progression during Chronic Fibrosis In Vivo. PLoS One. 2015; 10(6):e0128466. PMID: 26030283.
      Citations: 1     Fields:    Translation:AnimalsCells
    13. Sällberg M, Frelin L, Ahlén G, Sällberg-Chen M. Electroporation for therapeutic DNA vaccination in patients. Med Microbiol Immunol. 2015 Feb; 204(1):131-5. PMID: 25535102.
      Citations: 5     Fields:    Translation:HumansCellsPHPublic Health
    14. Brenndörfer ED, Brass A, Karthe J, Ahlén G, Bode JG, Sällberg M. Cleavage of the T cell protein tyrosine phosphatase by the hepatitis C virus nonstructural 3/4A protease induces a Th1 to Th2 shift reversible by ribavirin therapy. J Immunol. 2014 Feb 15; 192(4):1671-80. PMID: 24442435.
      Citations: 6     Fields:    Translation:AnimalsCells
    15. Koh S, Shimasaki N, Suwanarusk R, Ho ZZ, Chia A, Banu N, Howland SW, Ong AS, Gehring AJ, Stauss H, Renia L, Sällberg M, Campana D, Bertoletti A. A practical approach to immunotherapy of hepatocellular carcinoma using T cells redirected against hepatitis B virus. Mol Ther Nucleic Acids. 2013 Aug 13; 2:e114. PMID: 23941866.
      Citations: 39     
    16. Ahlén G, Frelin L, Brenndörfer ED, Brass A, Weiland O, Chen M, Sällberg M. Containing "The Great Houdini" of viruses: combining direct acting antivirals with the host immune response for the treatment of chronic hepatitis C. Drug Resist Updat. 2013 Jul-Nov; 16(3-5):60-7. PMID: 23911647.
      Citations: 8     Fields:    Translation:HumansAnimalsCells
    17. Fournillier A, Frelin L, Jacquier E, Ahlén G, Brass A, Gerossier E, Holmström F, Broderick KE, Sardesai NY, Bonnefoy JY, Inchauspé G, Sällberg M. A heterologous prime/boost vaccination strategy enhances the immunogenicity of therapeutic vaccines for hepatitis C virus. J Infect Dis. 2013 Sep; 208(6):1008-19. PMID: 23776192.
      Citations: 20     Fields:    Translation:AnimalsCellsPHPublic Health
    18. Weiland O, Ahlén G, Diepolder H, Jung MC, Levander S, Fons M, Mathiesen I, Sardesai NY, Vahlne A, Frelin L, Sällberg M. Therapeutic DNA vaccination using in vivo electroporation followed by standard of care therapy in patients with genotype 1 chronic hepatitis C. Mol Ther. 2013 Sep; 21(9):1796-805. PMID: 23752314.
      Citations: 28     Fields:    Translation:HumansCellsCTClinical Trials
    19. Rahbin N, Frelin L, Aleman S, Hultcrantz R, Sällberg M, Brenndörfer ED. Non-structural 3 protein expression is associated with T cell protein tyrosine phosphatase and viral RNA levels in chronic hepatitis C patients. Biochem Biophys Res Commun. 2013 Mar 29; 433(1):31-5. PMID: 23454379.
      Citations: 2     Fields:    Translation:HumansCells
    20. Ahlén G, Sällberg M, Frelin L. Methods for monitoring gene gun-induced HBV- and HCV-specific immune responses in mouse models. Methods Mol Biol. 2013; 940:239-67. PMID: 23104348.
      Citations: 3     Fields:    Translation:AnimalsCells
    21. Pasetto A, Frelin L, Aleman S, Holmström F, Brass A, Ahlén G, Brenndörfer ED, Lohmann V, Bartenschlager R, Sällberg M, Bertoletti A, Chen M. TCR-redirected human T cells inhibit hepatitis C virus replication: hepatotoxic potential is linked to antigen specificity and functional avidity. J Immunol. 2012 Nov 01; 189(9):4510-9. PMID: 23024278.
      Citations: 10     Fields:    Translation:HumansAnimalsCells
    22. Brenndörfer ED, Sällberg M. Hepatitis C virus-mediated modulation of cellular immunity. Arch Immunol Ther Exp (Warsz). 2012 Oct; 60(5):315-29. PMID: 22911132.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    23. Perdomo MF, Sällberg M, Vahlne A. HIV inhibition by CD4 and CCR5-derived glycopeptides. AIDS Res Hum Retroviruses. 2012 Sep; 28(9):1052-8. PMID: 22559037.
      Citations:    Fields:    Translation:HumansCells
    24. Malik IR, Chen A, Brass A, Ahlén G, Rahman M, Sällberg M, Qureshi JA, Frelin L. A bi-functional hepatitis B virus core antigen (HBcAg) chimera activates HBcAg-specific T cells and preS1-specific antibodies. Scand J Infect Dis. 2012 Jan; 44(1):55-9. PMID: 21933033.
      Citations: 2     Fields:    Translation:AnimalsCellsPHPublic Health
    25. Brenndörfer ED, Brass A, Söderholm J, Frelin L, Aleman S, Bode JG, Sällberg M. Hepatitis C virus non-structural 3/4A protein interferes with intrahepatic interferon-? production. Gut. 2012 Apr; 61(4):589-96. PMID: 21813471.
      Citations: 6     Fields:    Translation:HumansAnimalsCells
    26. Söderberg C, Marmur J, Eckes K, Glaumann H, Sällberg M, Frelin L, Rosenberg P, Stål P, Hultcrantz R. Microvesicular fat, inter cellular adhesion molecule-1 and regulatory T-lymphocytes are of importance for the inflammatory process in livers with non-alcoholic steatohepatitis. APMIS. 2011 Jul; 119(7):412-20. PMID: 21635548.
      Citations: 13     Fields:    Translation:HumansCells
    27. Chen A, Ahlén G, Brenndörfer ED, Brass A, Holmström F, Chen M, Söderholm J, Milich DR, Frelin L, Sällberg M. Heterologous T cells can help restore function in dysfunctional hepatitis C virus nonstructural 3/4A-specific T cells during therapeutic vaccination. J Immunol. 2011 May 01; 186(9):5107-18. PMID: 21430225.
      Citations: 9     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    28. Frelin L, Brass A, Ahlén G, Brenndörfer ED, Chen M, Sällberg M. Electroporation: a promising method for the nonviral delivery of DNA vaccines in humans? Drug News Perspect. 2010 Dec; 23(10):647-53. PMID: 21180650.
      Citations: 5     Fields:    Translation:HumansAnimals
    29. Brenndörfer ED, Weiland M, Frelin L, Derk E, Ahlén G, Jiao J, Bode JG, Sällberg M. Anti-tumor necrosis factor a treatment promotes apoptosis and prevents liver regeneration in a transgenic mouse model of chronic hepatitis C. Hepatology. 2010 Nov; 52(5):1553-63. PMID: 20886569.
      Citations: 15     Fields:    Translation:HumansAnimals
    30. Witthajitsomboon N, Chen A, Lorroengsil S, Sällberg M, Pantuwatana S. Cloning and expression of envelope protein of Thai genotype I strain KE-093 of Japanese encephalitis virus. Southeast Asian J Trop Med Public Health. 2010 Nov; 41(6):1359-67. PMID: 21329311.
      Citations:    Fields:    Translation:Cells
    31. Nyström J, Chen A, Frelin L, Ahlén G, Koh S, Brass A, Peterson DL, Fons M, Milich DR, Hultgren C, Sällberg M. Improving on the ability of endogenous hepatitis B core antigen to prime cytotoxic T lymphocytes. J Infect Dis. 2010 Jun 15; 201(12):1867-79. PMID: 20446851.
      Citations: 6     Fields:    Translation:AnimalsCells
    32. Kriegs M, Bürckstümmer T, Himmelsbach K, Bruns M, Frelin L, Ahlén G, Sällberg M, Hildt E. The hepatitis C virus non-structural NS5A protein impairs both the innate and adaptive hepatic immune response in vivo. J Biol Chem. 2009 Oct 09; 284(41):28343-28351. PMID: 19674968.
      Citations: 19     Fields:    Translation:AnimalsCells
    33. Sällberg M, Frelin L, Weiland O. DNA vaccine therapy for chronic hepatitis C virus (HCV) infection: immune control of a moving target. Expert Opin Biol Ther. 2009 Jul; 9(7):805-15. PMID: 19527105.
      Citations: 8     Fields:    Translation:HumansAnimals
    34. Brenndörfer ED, Karthe J, Frelin L, Cebula P, Erhardt A, Schulte am Esch J, Hengel H, Bartenschlager R, Sällberg M, Häussinger D, Bode JG. Nonstructural 3/4A protease of hepatitis C virus activates epithelial growth factor-induced signal transduction by cleavage of the T-cell protein tyrosine phosphatase. Hepatology. 2009 Jun; 49(6):1810-20. PMID: 19475692.
      Citations: 25     Fields:    Translation:HumansCells
    35. Sällberg M. Oral viral infections of children. Periodontol 2000. 2009 Feb; 49:87-95. PMID: 19152527.
      Citations: 6     Fields:    Translation:HumansCells
    36. Frelin L, Sällberg M. A small step closer to the Holy Grail of DNA vaccines: undisputed clinical benefit in humans. Genome Med. 2009 Jan 23; 1(1):15. PMID: 19348702.
      Citations: 1     Fields:    
    37. Nyström J, Cardell K, Björnsdottir TB, Fryden A, Hultgren C, Sällberg M. Improved cell mediated immune responses after successful re-vaccination of non-responders to the hepatitis B virus surface antigen (HBsAg) vaccine using the combined hepatitis A and B vaccine. Vaccine. 2008 Nov 05; 26(47):5967-72. PMID: 18804140.
      Citations: 13     Fields:    Translation:HumansCells
    38. Perdomo MF, Levi M, Sällberg M, Vahlne A. Neutralization of HIV-1 by redirection of natural antibodies. Proc Natl Acad Sci U S A. 2008 Aug 26; 105(34):12515-20. PMID: 18719129.
      Citations: 13     Fields:    Translation:HumansCells
    39. Cardell K, Akerlind B, Sällberg M, Frydén A. Excellent response rate to a double dose of the combined hepatitis A and B vaccine in previous nonresponders to hepatitis B vaccine. J Infect Dis. 2008 Aug 01; 198(3):299-304. PMID: 18544037.
      Citations: 24     Fields:    Translation:HumansCells
    40. Lorroengsil S, Chen A, Sällberg M, Pantuwatana S. Genetic differences of E gene of a Thai strain of Japanese encephalitis virus that determine small plaque size phenotype but not neurovirulence in suckling mice. Southeast Asian J Trop Med Public Health. 2008 May; 39(3):387-93. PMID: 18564676.
      Citations:    Fields:    Translation:HumansAnimalsCells
    41. Watts NR, Cardone G, Vethanayagam JG, Cheng N, Hultgren C, Stahl SJ, Steven AC, Sällberg M, Wingfield PT. Non-canonical binding of an antibody resembling a naïve B cell receptor immunoglobulin to hepatitis B virus capsids. J Mol Biol. 2008 Jun 20; 379(5):1119-29. PMID: 18486949.
      Citations: 8     Fields:    Translation:AnimalsCells
    42. Ahlén G, Söderholm J, Tjelle T, Kjeken R, Frelin L, Höglund U, Blomberg P, Fons M, Mathiesen I, Sällberg M. In vivo electroporation enhances the immunogenicity of hepatitis C virus nonstructural 3/4A DNA by increased local DNA uptake, protein expression, inflammation, and infiltration of CD3+ T cells. J Immunol. 2007 Oct 01; 179(7):4741-53. PMID: 17878373.
      Citations: 53     Fields:    Translation:AnimalsCellsPHPublic Health
    43. Desombere I, Van Vlierberghe H, Weiland O, Hultgren C, Sällberg M, Quiroga J, Carreño V, Leroux-Roels G. Serum levels of anti-NS4a and anti-NS5a predict treatment response of patients with chronic hepatitis C. J Med Virol. 2007 Jun; 79(6):701-13. PMID: 17457916.
      Citations: 3     Fields:    Translation:Humans
    44. Björnsdottir TB, Stanzeit B, Sällberg M, Löve A, Hultgren C. Changing prevalence of hepatitis B virus genotypes in Iceland. J Med Virol. 2005 Dec; 77(4):481-5. PMID: 16254980.
      Citations: 3     Fields:    Translation:HumansCells
    45. Chen M, Sällberg M, Hughes J, Jones J, Guidotti LG, Chisari FV, Billaud JN, Milich DR. Immune tolerance split between hepatitis B virus precore and core proteins. J Virol. 2005 Mar; 79(5):3016-27. PMID: 15709022.
      Citations: 72     Fields:    Translation:AnimalsCells
    46. Chen MT, Billaud JN, Sällberg M, Guidotti LG, Chisari FV, Jones J, Hughes J, Milich DR. A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen. Proc Natl Acad Sci U S A. 2004 Oct 12; 101(41):14913-8. PMID: 15469922.
      Citations: 91     Fields:    Translation:AnimalsCells
    47. Hultgren C, Desombere I, Leroux-Roels G, Quiroga JA, Carreno V, Nilsson B, Weiland O, Sällberg M. Evidence for a relation between the viral load and genotype and hepatitis C virus-specific T cell responses. J Hepatol. 2004 Jun; 40(6):971-8. PMID: 15158338.
      Citations: 6     Fields:    Translation:HumansCells
    48. Karlsson AC, Deeks SG, Barbour JD, Heiken BD, Younger SR, Hoh R, Lane M, Sällberg M, Ortiz GM, Demarest JF, Liegler T, Grant RM, Martin JN, Nixon DF. Dual pressure from antiretroviral therapy and cell-mediated immune response on the human immunodeficiency virus type 1 protease gene. J Virol. 2003 Jun; 77(12):6743-52. PMID: 12767994.
      Citations: 20     Fields:    Translation:HumansCells
    49. Wade D, Flock JI, Edlund C, Löfving-Arvholm I, Sällberg M, Bergman T, Silveira A, Unson C, Rollins-Smith L, Silberring J, Richardson M, Kuusela P, Lankinen H. Antibiotic properties of novel synthetic temporin A analogs and a cecropin A-temporin A hybrid peptide. Protein Pept Lett. 2002 Dec; 9(6):533-43. PMID: 12553862.
      Citations: 2     Fields:    Translation:Humans
    50. Rico MA, Quiroga JA, Subirá D, Garcia E, Castañón S, Sällberg M, Leroux-Roels G, Weiland O, Pardo M, Carreño V. Features of the CD4+ T-cell response in liver and peripheral blood of hepatitis C virus-infected patients with persistently normal and abnormal alanine aminotransferase levels. J Hepatol. 2002 Mar; 36(3):408-16. PMID: 11867186.
      Citations: 10     Fields:    Translation:HumansCells
    51. Sällberg M, Hughes J, Jones J, Phillips TR, Milich DR. A malaria vaccine candidate based on a hepatitis B virus core platform. Intervirology. 2002; 45(4-6):350-61. PMID: 12602355.
      Citations: 5     Fields:    Translation:AnimalsCellsPHPublic Health